$CRMD Cormedix (NYSEMKT:CRMD) price target raised to $4 (751% upside) from $3 by H.C. Wainwright citing attractiveness of device pipeline.
<ticker> <company> nysemkt : crmd price target raised to $ <number> <number> % upside from $ <number> by h . c . wainwright citing attractiveness of device pipeline .